Literature DB >> 6882744

Solubilization of low-density lipoprotein with sodium deoxycholate and recombination of apoprotein B with dimyristoylphosphatidylcholine.

M T Walsh, D Atkinson.   

Abstract

Apoprotein B (apoB) of human plasma low-density lipoprotein (LDL) (d 1.025-1.050 g/mL) has been solubilized with solid sodium deoxycholate (NaDC) above its critical micellar concentration. ApoB is isolated by gel-filtration chromatography as a mixed micellar complex of protein and detergent in high yield in a lipid-free form. A soluble apoB-dimyristoylphosphatidylcholine (DMPC) complex has been prepared by incubation of aqueous solutions of apoB-NaDC and DMPC-NaDC (2/1 w/w) at room temperature with detergent removal by extensive dialysis. A combination of gel chromatographic and density gradient fractionation of DMPC-apoB incubation mixtures demonstrates that a reasonably well-defined complex of DMPC and apoB is formed with a 4:1 w/w lipid:protein ratio. Negative-stain electron microscopy shows these particles to be single-bilayer phospholipid vesicles with a diameter of 210 +/- 20 A into which the apoB is incorporated. Circular dichroic spectra of NaDC-solubilized apoB show apoB to have similar conformation to that seen in the native LDL particle. However, apoB that has been complexed with DMPC exhibits more alpha-helix. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis shows a single band (apparent Mr 366000) for apoB after solubilization, purification, and interaction with phospholipid. The behavior of apoB during its reassociation with phospholipid and the structural features of the DMPC-apoB particle are similar to those observed in the interaction of solubilized membrane proteins with lipid rather than that of other apo-lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6882744     DOI: 10.1021/bi00282a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces.

Authors:  Libo Wang; Mary T Walsh; Donald M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD.

Authors:  Ling Li; Gurkan Bebek; Stephen F Previs; Jonathan D Smith; Rovshan G Sadygov; Arthur J McCullough; Belinda Willard; Takhar Kasumov
Journal:  J Proteome Res       Date:  2016-08-05       Impact factor: 4.466

3.  Elucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid.

Authors:  Rohit S Mulik; Hui Zheng; Kumar Pichumani; James Ratnakar; Qiu-Xing Jiang; Ian R Corbin
Journal:  Chem Phys Lipids       Date:  2017-03-22       Impact factor: 3.329

Review 4.  Learning from biology: synthetic lipoproteins for drug delivery.

Authors:  Huang Huang; William Cruz; Juan Chen; Gang Zheng
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-24

5.  Molecular structure of low density lipoprotein: current status and future challenges.

Authors:  Ruth Prassl; Peter Laggner
Journal:  Eur Biophys J       Date:  2008-09-17       Impact factor: 1.733

6.  Expression, secretion, and lipid-binding characterization of the N-terminal 17% of apolipoprotein B.

Authors:  H Herscovitz; M Hadzopoulou-Cladaras; M T Walsh; C Cladaras; V I Zannis; D M Small
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

7.  Structural analysis of reconstituted lipoproteins containing the N-terminal domain of apolipoprotein B.

Authors:  Zhenghui Gordon Jiang; Martha N Simon; Joseph S Wall; C James McKnight
Journal:  Biophys J       Date:  2007-03-16       Impact factor: 4.033

8.  Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: 2H2O-Metabolic Labeling-Based Kinetic Approach.

Authors:  Prabodh Sadana; Li Lin; Mirjavid Aghayev; Serguei Ilchenko; Takhar Kasumov
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.